SEARCH

SEARCH BY CITATION

References

  • Al-Fattani MA & Douglas LJ (2004) Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Ch 48: 32913297.
  • Berna A, Scott K, Chabrière E & Bernier F (2009) The DING family of proteins: ubiquitous in eukaryotes, but where are the genes? Bioessays 31: 570580.
  • Blankenship JR & Mitchell AP (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9: 588594.
  • Borecká-Melkusová S & Bujdáková H (2008) Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment. Can J Microbiol 54: 718724.
  • Bujdáková H, Würzner R, Klobušický M & Dierich MP (1997) Expression and quantification of the iC3b-binding protein in different Candida albicans strains and their morphological stages. FEMS Immunol Med Mic 18: 147152.
  • Bujdáková H, Lell CP, Gruber A, Langgartner M, Spötl L, Kurišková S, Klobušický M, Dierich MP & Würzner R (1999) The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation. FEMS Immunol Med Mic 26: 110.
  • Bujdáková H, Paulovičová E, Borecká-Melkusová S et al. (2008) Antibody response to the 45 kDa Candida albicans antigen in animal model and its potential role in adherence. J Med Microbiol 57: 14661472.
  • Cateau E, Levasseur P, Borgonovi M & Imbert C (2007) The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin. Clin Microbiol Infec 13: 311315.
  • Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 53855394.
  • Dorocka-Bobkowska B, Dűzgűneş H & Konopka K (2009) AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment. Med Sci Monitor 15: 262269.
  • Dovigo LN, Pavarina AC, De Oliveira Mima EG, Giampaolo ET, Vergani CE & Bagnato VS (2009) Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses, Epub ahead of print.
  • Fujibayashi T, Nakamura M, Tominaga A, Satoh N, Kawarai T, Narisawa N, Shinozuka O, Watanabe H, Yamazaki T & Senpuku H (2009) Effect of IgY against Candida albicans and Candida spp. adherence and biofilm formation. Jpn J Infect Dis 62: 337342.
  • Gilmore JB, Retsinas EM, Lorenz JS & Hostetter M (1988) An iC3b receptor on Candida albicans: structure, function and correlates for pathogenicity. J Infect Dis 157: 3846.
  • Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA & Hoyer LL (2004) RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology 150: 267275.
  • Heidenreich F & Dierich MP (1985) Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect Immun 50: 598600.
  • Henriques M, Cerca N, Azeredo J & Oliveira R (2005) Influence of sub-inhibitory concentrations of antifungal agents on biofilm in indwelling devices. Int J Artif Organs 28: 11811185.
  • Henriques M, Azeredo J & Oliveira R (2007) The involvement of physico-chemical interactions in the adhesion of Candida albicans and Candida dubliniensis to epithelial cells. Mycoses 50: 391396.
  • Hostetter MK (1996) An integrin-like protein in Candida albicans: implications for pathogenesis. Trends Microbiol 4: 242246.
  • Hostetter MK, Lorenz JS, Preus L & Kendrick KE (1990) The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J Infect Dis 161: 761768.
  • Ibrahim AS, Spellberg BJ, Avenissian V, Fu Y, Filler SG & Edwards JE (2005) Vaccination with recombinant N-terminal domain of ALS1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73: 9991005.
  • Kojic EM & Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17: 255267.
  • Kuhn DM, George T, Chandra J, Mukherjee PK & Ghannoum MA (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphothericin B lipid formulations and echinocandins. Antimicrob Agents Ch 46: 17731780.
  • Li X, Yan Z & Xu J (2003) Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149: 353362.
  • Maza EN, Moraques MD & Pontón J (2009) Monoclonal antibody-mediated inhibition of adhesion of Candida albicans and Candida dubliniensis to human epithelial cells. Eur J Oral Sci 117: 474478.
  • Müller P, Guggenheim B & Schmidlin PR (2007) Efficacy of gasiform ozone and photodynamic therapy on a multispecies oral biofilm in vitro. Eur J Oral Sci 115: 7780.
  • Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D & Nelis HJ (2006) Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilm by real-time PCR. BMC Mol Biol 4: 725.
  • Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR & Mitchell AP (2008) Complementary adhesin function in C. albicans biofilm. Curr Biol 18: 10171024.
  • Nobile JC, Andes DR, Nett JE, Smith FJ Jr, Yue F, Phan QT, Edwards JE Jr, Filler SG & Mitchell AP (2006) Critical role of Bcr1-dependent adhesins in Candida albicans biofilm formation in vitro and in vivo. PLoS Pathog 2: e63.
  • Opilla M & Grove E (2008) Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 36: 173.e5173.e8.
  • Paulovičová E, Bystrický S, Machová E & Bujdáková H (2008) Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: mannan and CR3-related protein. FEMS Immunol Med Mic 58: 421428.
  • Ramage G, Martínez JP & López-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 7: 979986.
  • Rodier MH, Imbert C, Kauffmann-Lacroix C, Daniault G & Jacquemin JL (2003) Immunoglobulins G could prevent adherence of Candida albicans to polystyrene and extracellular matrix components. J Med Microbiol 52: 373377.
  • Seidler M, Salvenmoser S & Müller FM (2006) In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Ag 28: 568573.
  • Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH & Samaranayake LP (2009) Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata. Arch Oral Biol 54: 10521060.
  • Sohn K, Senyürek I, Fertey J, Königsdorfer A, Joffroy C, Hauser N, Zelt G, Brunner H & Rupp S (2006) An in vitro assay to study the transcriptional response during adherence of Candida albicans to different human epithelia. FEMS Yeast Res 6: 10851093.
  • Soll DR (2008) Candida biofilms: is adhesion sexy? Curr Biol 18: 5759.
  • Voller A (1978) The enzyme-linked immunosorbent assay (ELISA) (theory, technique and applications). Ric Clin Lab 8: 289298.
  • Wright SD, Rao PE, Van Voorhis WC, Craigmyle LS, Iida K, Talle MA, Westberg EF, Goldstein G & Silverstein SC (1983) Identification of the iC3b receptor of human monocytes and macrophages by using monoclonal antibodies. P Natl Acad Sci USA 80: 56995703.